Literature DB >> 29984661

Role of C1858T Polymorphism of Lymphoid Tyrosine Phosphatase in Egyptian Children and Adolescents with Type 1 Diabetes.

Wafaa Moustafa M Abo El Fotoh1, Dina Abd El Razek Midan1, Abeer Hamdy El Shalakany2.   

Abstract

BACKGROUND: Type 1 Diabetes Mellitus (T1DM) is a multifactorial autoimmune disease. The Protein Tyrosine Phosphatase Non-receptor 22 (PTPN22) gene is an important negative regulator of signal transduction through the T-cell Receptors (TCR). A PTPN22 polymorphism, C1858T, has been found to be a risk determinant for several autoimmune diseases, including T1DM, in different populations.
OBJECTIVE: The present study was aimed to analyze a possible association between the C1858T polymorphism in Egyptian children with T1DM.
METHODS: This case-control study included 240 children divided evenly between T1DM patients and controls. The PTPN22 C1858T polymorphism was genotyped using polymerase chain reaction with Restriction Fragment Length Polymorphism (RFLP).
RESULTS: Both the 1858CΤ and 1858ΤΤ genotypes and the 1858T allele were found more frequently in patients (32.5% and 18.7%, respectively) than in controls (10% and 5.0%, respectively), P=0.013 and P=0.007, respectively. Among females, the 1858T allele was more common in patients (18%) than in controls (2.6%), P=0.014.
CONCLUSION: These findings suggest that the PTPN22 1858T allele could be a T1DM susceptibility factor in the Egyptian population and that it might play a different role in susceptibility to T1DM according to gender in T1DM patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  C1858T; Egyptian; PTPN22; Polymorphism; RFLP; T1DM.

Mesh:

Substances:

Year:  2019        PMID: 29984661     DOI: 10.2174/1573399814666180709102533

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  1 in total

1.  Association of PTPN22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population-A preliminary study.

Authors:  Natalia Wawrusiewicz-Kurylonek; Olga Martyna Koper-Lenkiewicz; Joanna Gościk; Janusz Myśliwiec; Przemysław Pawłowski; Adam Jacek Krętowski
Journal:  Mol Genet Genomic Med       Date:  2019-04-01       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.